Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.32 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22480673 | 0.96 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL22150218 | 0.95 | ALOX5 (0.39) | ALOX5GGPS1PRKDCPTGES2 | |
| SCHEMBL22480648 | 0.95 | ALOX5 (0.40) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL22480602 | 0.95 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL23769802 | 0.95 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL23770217 | 0.94 | ALOX5 (0.39) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL23770216 | 0.94 | ALOX5 (0.39) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL22151759 | 0.94 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2PLA2G2A | |
| SCHEMBL21563651 | 0.94 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2CDC14B | |
| SCHEMBL31511478 | 0.94 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2CDC14B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230108986-A1 | ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-04-06 | — | — | US | disclosed |
| US-20230058635-A1 | ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-20200308129-A1 | SUBSTITUTED AROMATIC AMINES FOR USE IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308129-A1 | SUBSTITUTED AROMATIC AMINES FOR USE IN ORGANIC ELECTROLUMINESCENT DEVICES | DDC, CHRM5, AFF2 | ALOX5 2670/4885GGPS1 2850/4885PRKDC 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.